TY - JOUR
T1 - Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency
AU - Wang, Heng
AU - Bright, Alicia
AU - Xin, Baozhong
AU - Bockoven, J. R.
AU - Paller, Amy
PY - 2013/4/1
Y1 - 2013/4/1
N2 - Ganglioside GM3 synthase deficiency is a rare autosomal recessive metabolic disorder characterized by infantile onset of severe irritability and epilepsy, failure to thrive, developmental stagnation, and cortical blindness. Because of the lack of easily recognizable dysmorphism and specific neurologic manifestations, identification of patients with this condition is extremely challenging. Here we report on previously undescribed pigmentary abnormalities in 20 of 38 patients with GM3 synthase deficiency. All 20 of the patients showed freckle-like hyperpigmented macules, ranging in size from 2 to 5mm in diameter and usually found bilaterally on the extremities, especially the dorsal aspects of the hands and feet. Seven of these patients also had depigmented macules and patches, especially on the face and extremities. These cutaneous changes were asymptomatic, and were not associated with the severity or particular phenotype of the neurologic disease. They became visible only after the first years of life with an increased incidence with advancing age. These distinct pigmentary features are not identified in 54 normal siblings, and may provide a useful clue in identifying patients with ganglioside metabolic disorders.
AB - Ganglioside GM3 synthase deficiency is a rare autosomal recessive metabolic disorder characterized by infantile onset of severe irritability and epilepsy, failure to thrive, developmental stagnation, and cortical blindness. Because of the lack of easily recognizable dysmorphism and specific neurologic manifestations, identification of patients with this condition is extremely challenging. Here we report on previously undescribed pigmentary abnormalities in 20 of 38 patients with GM3 synthase deficiency. All 20 of the patients showed freckle-like hyperpigmented macules, ranging in size from 2 to 5mm in diameter and usually found bilaterally on the extremities, especially the dorsal aspects of the hands and feet. Seven of these patients also had depigmented macules and patches, especially on the face and extremities. These cutaneous changes were asymptomatic, and were not associated with the severity or particular phenotype of the neurologic disease. They became visible only after the first years of life with an increased incidence with advancing age. These distinct pigmentary features are not identified in 54 normal siblings, and may provide a useful clue in identifying patients with ganglioside metabolic disorders.
KW - Cutaneous dyspigmentation
KW - Depigmentation
KW - Ganglioside GM3 synthase deficiency
KW - Hyperpigmentation
KW - Phenotype
KW - ST3GAL5
UR - http://www.scopus.com/inward/record.url?scp=84875487645&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875487645&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.35826
DO - 10.1002/ajmg.a.35826
M3 - Article
C2 - 23436467
AN - SCOPUS:84875487645
SN - 1552-4825
VL - 161
SP - 875
EP - 879
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 4
ER -